NANOG as prognostic factor of prostate cancer course

Summary. The variability of the clinical course of prostate cancer (PC) indicates the need to find factors that could predict the aggressive potential of neoplasms accounting the biological characteristics of tumor cells. In this context, the role of NANOG, a transcription factor involved in maintai...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Datum:2023
Hauptverfasser: Zadvornyi, T.V., Lukianova, N.Yu., Borikun, T.V., Vitruk, Yu.V., Stakhovsky, E.O., Chekhun, V.F.
Format: Artikel
Sprache:English
Veröffentlicht: PH Akademperiodyka 2023
Schlagworte:
Online Zugang:https://exp-oncology.com.ua/index.php/Exp/article/view/2020-2-8
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Experimental Oncology

Institution

Experimental Oncology